Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 10.73% | 61.50 | 0.0% | $1907.60m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 5.98% | 612.81 | 2.5% | $1175.40m | |
| GILD | Gilead Sciences, Inc. | 3.33% | 77.83 | 1.0% | $1168.63m | |
| AMGN | Amgen, Inc. | 2.49% | 229.70 | 1.3% | $672.54m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.81% | 287.96 | 1.9% | $606.67m | |
| NVAX | Novavax, Inc. | 2.68% | 46.04 | 102.0% | $590.02m | |
| BIIB | Biogen, Inc. | 2.19% | 307.09 | 1.6% | $417.42m | |
| ILMN | Illumina, Inc. | -2.67% | 363.05 | 3.5% | $387.48m | |
| SRNE | Sorrento Therapeutics, Inc. | 2.02% | 5.05 | 1.8% | $306.68m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 4.79% | 119.90 | 2.0% | $292.13m | |
| SGEN | Seattle Genetics, Inc. | 3.74% | 157.21 | 6.1% | $269.08m | |
| A | Agilent Technologies, Inc. | 1.67% | 88.14 | 1.6% | $202.48m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.90% | 106.55 | 4.3% | $186.35m | |
| CODX | Co-Diagnostics, Inc. | 3.03% | 18.00 | 0.0% | $173.36m | |
| INCY | Incyte Corp. | 1.35% | 101.91 | 2.5% | $166.15m |
Company Profile
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.